Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VERA TROFIMENKO

Allopathic & Osteopathic Physicians Urology

NPI
1518224112
CMS profile
1384296
Location
SANTA ANA, CA

General Payments · PY2018–2024

$4,467.47

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$424.78

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $424.78 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BLUEWIND MEDICAL $121.54 1
Medtronic, Inc. $87.22 3
Teleflex LLC $69.84 4
ABBVIE INC. $43.16 2
Astellas Pharma US Inc $31.64 1
ACCORD HEALTHCARE, INC. $30.08 1
Myriad Genetic Laboratories, Inc. $26.37 1
COLOPLAST CORP $14.93 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $652.76 8
PY2019 $1,113.23 29
PY2020 $250.08 15
PY2021 $426.28 25
PY2022 $710.70 17
PY2023 $889.64 23
PY2024 $424.78 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.26 04/18/2024 Food and Beverage Undisputed 01/23/2026 1106245220 CMS
ABBVIE INC. $24.90 09/09/2024 Food and Beverage Undisputed 01/23/2026 1106245222 CMS
ACCORD HEALTHCARE, INC. $30.08 07/08/2024 Food and Beverage Undisputed 01/23/2026 1120080484 CMS
Astellas Pharma US Inc $31.64 02/02/2024 Food and Beverage Undisputed 01/23/2026 1139299328 CMS
BLUEWIND MEDICAL $121.54 01/18/2024 Food and Beverage Undisputed 01/23/2026 1126547542 CMS
COLOPLAST CORP $14.93 10/27/2024 Food and Beverage Undisputed 01/23/2026 1117438155 CMS
Medtronic, Inc. $24.07 05/14/2024 Food and Beverage Undisputed 01/23/2026 1119355474 CMS
Medtronic, Inc. $48.77 07/18/2024 Food and Beverage Undisputed 01/23/2026 1119355476 CMS
Medtronic, Inc. $14.38 10/03/2024 Food and Beverage Undisputed 01/23/2026 1119355478 CMS
Myriad Genetic Laboratories, Inc. $26.37 12/09/2024 Food and Beverage Undisputed 01/23/2026 1152541519 CMS
Teleflex LLC $18.39 05/20/2024 Food and Beverage Undisputed 01/23/2026 1142099249 CMS
Teleflex LLC $15.00 07/16/2024 Food and Beverage Undisputed 01/23/2026 1142090725 CMS
Teleflex LLC $18.76 07/17/2024 Food and Beverage Undisputed 01/23/2026 1142082236 CMS
Teleflex LLC $17.69 09/04/2024 Food and Beverage Undisputed 01/23/2026 1142095057 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.